Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Rapamune 1mg tablets
0802020U0BBADAD
|
Rapamune | Sirolimus | Malignant Disease and Immunosuppression | 77 |
|
Mercaptopurine 10mg capsules
0801030L0AAAGAG
|
Mercaptopurine | Mercaptopurine | Malignant Disease and Immunosuppression | 76 |
|
Methotrexate 10mg/0.4ml inj pre-filled syringes
0801030P0AAFHFH
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 75 |
|
Casodex 150mg tablets
0803042A0BBABAB
|
Casodex | Bicalutamide | Malignant Disease and Immunosuppression | 73 |
|
Envarsus 4mg modified-release tablets
0802020T0BJACBE
|
Envarsus | Tacrolimus | Malignant Disease and Immunosuppression | 73 |
|
Triptorelin acetate 3.75mg inj pre-filled syringes
0803042P0AAABAB
|
Triptorelin (acetate) | Triptorelin acetate | Malignant Disease and Immunosuppression | 73 |
|
Octreotide 50micrograms/1ml solution for injection ampoules
0803043N0AAAAAA
|
Octreotide acetate | Octreotide acetate | Malignant Disease and Immunosuppression | 72 |
|
Azathioprine 50mg/5ml oral suspension sugar free
0802010G0AACPCP
|
Azathioprine | Azathioprine | Malignant Disease and Immunosuppression | 71 |
|
Tacrolimus 2mg capsules
0802020T0AABGBG
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | 70 |
|
Azathioprine 50mg/5ml oral solution
0802010G0AAAPAP
|
Azathioprine | Azathioprine | Malignant Disease and Immunosuppression | 68 |
|
Somatuline Autogel 90mg/0.5ml inj pfs with safety system
0803043P0BBAFAF
|
Somatuline | Lanreotide | Malignant Disease and Immunosuppression | 66 |
|
Azathioprine 100mg/5ml oral suspension
0802010G0AACJCJ
|
Azathioprine | Azathioprine | Malignant Disease and Immunosuppression | 63 |
|
Refolinon 15mg tablets
0801000I0BBAAAH
|
Calcium leucovorin lederle | Calcium folinate | Malignant Disease and Immunosuppression | 59 |
|
Sandostatin LAR 10mg inj vials
0803043N0BBAEAE
|
Sandostatin | Octreotide acetate | Malignant Disease and Immunosuppression | 59 |
|
Ceptava 360mg gastro-resistant tablets
0802010N0BCABAB
|
Ceptava | Mycophenolic sodium | Malignant Disease and Immunosuppression | 58 |
|
Octreotide 50micrograms/1ml inj pre-filled syringes
0803043N0AAANAN
|
Octreotide acetate | Octreotide acetate | Malignant Disease and Immunosuppression | 57 |
|
Envarsus 750microgram modified-release tablets
0802020T0BJABBD
|
Envarsus | Tacrolimus | Malignant Disease and Immunosuppression | 56 |
|
Octreotide 1mg/5ml solution for injection vials
0803043N0AAADAD
|
Octreotide acetate | Octreotide acetate | Malignant Disease and Immunosuppression | 56 |
|
Vanquoral 50mg capsules
0802020G0BHABAF
|
Vanquoral | Ciclosporin | Malignant Disease and Immunosuppression | 56 |
|
Methotrexate 22.5mg/0.9ml inj pre-filled syringes
0801030P0AAFFFF
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 52 |
|
Methotrexate 7.5mg/0.3ml inj pre-filled syringes
0801030P0AAFIFI
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 51 |
|
Sirolimus 1mg/ml oral solution sugar free
0802020U0AAACAC
|
Sirolimus | Sirolimus | Malignant Disease and Immunosuppression | 51 |
|
Methotrexate 17.5mg/0.7ml inj pre-filled syringes
0801030P0AAFLFL
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 50 |
|
Vanquoral 25mg capsules
0802020G0BHAAAC
|
Vanquoral | Ciclosporin | Malignant Disease and Immunosuppression | 49 |
|
Vanquoral 100mg capsules
0802020G0BHACAD
|
Vanquoral | Ciclosporin | Malignant Disease and Immunosuppression | 48 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.